“…[ 3 , 4 , 5 , 6 , 7 , 8 , 9 ] In particular, nanomaterials that can mimic oxidoreductases like peroxidase (POD), oxidase (OXD), and catalase (CAT) have sparked increasing interest because they can be used to fine‐tune local ROS levels for satisfactory bactericidal outcomes. [ 10 , 11 , 12 , 13 , 14 , 15 ] But these oxidoreductase‐mimicking nanomaterials, also known as bionanocatalysts, can show undesirable off‐target activity during in vivo biofilm treatment, leading to unpredictable toxicity. [ 16 , 17 ] Therefore, the ideal bionanocatalyst will not only deliver strong catalytic‐reaction‐based therapeutic effects to biofilm‐infected sites, but will limit its action to these sites while leaving healthy tissues unaffected.…”